Culturally Relevant Tools to Increase Hepatitis B Screening in Asian American Communities

Culturally Relevant Tools to Increase Hepatitis B Screening in Asian American Communities

Infection with hepatitis B poses a serious risk to the health of many Americans – especially in certain groups with high risk, including Asian Americans and Asian-American immigrants. Research has found that, to support universal adult screening recommendations, culturally- and linguistically- appropriate educational tools can increase the rate of screening.

read more
Global Liver Institute Leads Efforts in Urging FDA to Recognize Patient-Defined Progress in Drug Development

Global Liver Institute Leads Efforts in Urging FDA to Recognize Patient-Defined Progress in Drug Development

At the Global Liver Institute, we believe that it all starts with a patient because only they define what progress means to their lives. By elevating their lived experiences, we ensure that science, policy, and care move in the direction that matters most: toward earlier answers, more options, and a better standard of care.

read more
Global Liver Institute Leads Efforts in Urging FDA to Recognize Patient-Defined Progress in Drug Development

Global Fatty Liver Day 2025: Elevating Liver Health in the Metabolic Health Conversation

On the second Thursday in June, Global Fatty Liver Day (formerly International NASH Day) spotlights one of the most widespread yet under-addressed health threats of our time: fatty liver disease, increasingly referred to as steatotic liver disease (SLD) in clinical settings. Hosted annually by Global Liver Institute (GLI), this public awareness campaign raises awareness of this silent epidemic and its deep roots in global metabolic health challenges.

read more

Post Categories